Literature DB >> 30355622

β-Amyloid Accumulation Slows Earlier than Expected in Preclinical Alzheimer's Disease Patients.

Henrique Camara1, Evandro A De-Souza2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30355622      PMCID： PMC6705993          DOI： 10.1523/JNEUROSCI.1592-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  22 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

Review 3.  The therapeutics of Alzheimer's disease: where we stand and where we are heading.

Authors:  Dennis J Selkoe
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

4.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

5.  TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.

Authors:  Yingjun Zhao; Xilin Wu; Xiaoguang Li; Lu-Lin Jiang; Xun Gui; Yan Liu; Yu Sun; Bing Zhu; Juan C Piña-Crespo; Muxian Zhang; Ningyan Zhang; Xiaochun Chen; Guojun Bu; Zhiqiang An; Timothy Y Huang; Huaxi Xu
Journal:  Neuron       Date:  2018-03-07       Impact factor: 17.173

6.  Subthreshold Amyloid Predicts Tau Deposition in Aging.

Authors:  Stephanie L Leal; Samuel N Lockhart; Anne Maass; Rachel K Bell; William J Jagust
Journal:  J Neurosci       Date:  2018-04-23       Impact factor: 6.167

Review 7.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

Authors:  Christian Haass; Dennis J Selkoe
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

8.  Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.

Authors:  Yuesong Gong; Lei Chang; Kirsten L Viola; Pascale N Lacor; Mary P Lambert; Caleb E Finch; Grant A Krafft; William L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

Review 9.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

10.  Cerebral blood flow in Alzheimer's disease.

Authors:  Alex E Roher; Josef P Debbins; Michael Malek-Ahmadi; Kewei Chen; James G Pipe; Sharmeen Maze; Christine Belden; Chera L Maarouf; Pradeep Thiyyagura; Hua Mo; Jesse M Hunter; Tyler A Kokjohn; Douglas G Walker; Jane C Kruchowsky; Marek Belohlavek; Marwan N Sabbagh; Thomas G Beach
Journal:  Vasc Health Risk Manag       Date:  2012-10-23
View more
  4 in total

1.  Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Hongliang Liu; Michael Lutz; Sheng Luo
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 2.  Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease.

Authors:  Wenyue Wang; Sandeep Gopal; Roger Pocock; Zhicheng Xiao
Journal:  Molecules       Date:  2019-12-16       Impact factor: 4.411

3.  Astrocytes respond to a neurotoxic Aβ fragment with state-dependent Ca2+ alteration and multiphasic transmitter release.

Authors:  Cuong Pham; Karine Hérault; Martin Oheim; Steeve Maldera; Vincent Vialou; Bruno Cauli; Dongdong Li
Journal:  Acta Neuropathol Commun       Date:  2021-03-16       Impact factor: 7.801

Review 4.  Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.

Authors:  Martin Barak; Veronika Fedorova; Veronika Pospisilova; Jan Raska; Simona Vochyanova; Jiri Sedmik; Hana Hribkova; Hana Klimova; Tereza Vanova; Dasa Bohaciakova
Journal:  Stem Cell Rev Rep       Date:  2022-02-02       Impact factor: 5.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.